Chongqing Pharscin Pharmaceutical Co., Ltd. Stock Price

SZSE:002907 Community·CN¥5.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

002907 Share Price Performance

CN¥0

-16.65 (-100.00%)

CN¥0

-16.65 (-100.00%)

CN¥0

Tue, 30 Jun 26

Share Pricen/a

002907 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

3 Risks

0 Rewards

View Full Analysis

Chongqing Pharscin Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.14
: 57.33%
: 7.19%
: 0%

View Full Analysis

About 002907

Founded: 1996
Employees: 1439
CEO: Xiaoying Liu
WebsiteView website: www.pharscin.com

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.